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Fifty-eight patients admitted through our emergency room with severe skeletal muscle injury but no obvious cardiac contusions were evaluated for creatine kinase isoenzyme MB (CK-MB). When such patients show an above-normal value for total CK, it is a question of whether or not myocardiaI injury has been sustained along with skeletal muscle injury when (a) there are no obvious chest contusions or (b) the patient is unconscious and unable to complain of chest pain. Whenever there is doubt concerning the cardiac status of a patient, lactate dehydrogenase (LD) isoenzymes, serial electrocardiograms, and CK isoenzymes are ordered. Our study revealed that serum of 8.6% of the trauma victims had CK-MB values exceeding 5.0 EU/L (reflecting abnormal CK-MB concentrations) as part of their increased total CK. All patients had normal electrocardiographic patterns along with negative results for LD isoenzymes; none had sustained any demonstrable myocardlal injury. The CK-MB value must be interpreted together with the total CK value for appropriate diagnosis in patients with skeletal muscle trauma.
AddItIonal Keyphraaes: heart disease isoenzymes
Measurement of the MB isoenzyme of creatine kinase (CK) in serum is highly effective in assessing the possibility and extent of acute myocardial infarction (AM!) or, more broadly, in differentiating myocardial injury from skeletal muscle damage (1).3The ratio of CK-MB to CK-MM isoenzymes is markedly higher in myocardiuni than in skeletal muscles, and the presence of CK-MB activity in serum is generally considered indicative of AM! whenever it exceeds 5 EU/L of total CK activity (2, 3) per liter. The ad hoc expression "EU/L" is one way of expressing the immunological activity and is related to enzymatic activity. The CK-MB results from the calibration curve in the EMBRIA 5 EU/L, but no apparent myocardial injury. These unexpectedly high CK-MB fractions pose a dilemma for the physician. Our study investigated different seventies and etiologies of skeletal muscle trauma as we attempted to determine which typesof trauma were more likely to reveal an increased CK-MB fraction, and whether or not the increased CK-MB fraction indicated true myocardial damage.
Earlier., assays of the three CK isoenzymes-CK-BB, CK-MM, and CK-MB---reied primarily on electrophoresis and ion-exchange chromatography.
With recent advances in immunochemistry,
it is now possible to determine CK isoenzyme concentrations by means of immunoprecipitation or immunoinhibition with a specific antibody, followed by identification of functional enzymatic activity. It is difficult to measure accurately the amount of skeletal muscle damage in a trauma patient. Total CK was used in our study as a quantitative measurement of skeletal muscle trauma.
We also used new radioimmunoassay kits from
International Immunoassay Laboratories (for research only, not yet commercially available) for detecting CK-MM and CK-BB in trauma patients.
MaterIals and Methods

Patients and Samples
We studied 58 consecutive patients admitted through the emergency room after sustaining skeletal muscle trauma without apparent cardiac contusion. Blood was sampled from these patients at the time they were admitted to the emergency room.
Each trauma patient with a CK-MB value exceeding 5.0 EU/L was thoroughly evaluated for any possibility of myocardial damage. This evaluation included serial electrocardiograms, serial LD isoenzyme assays, serial cardiac examinations, and any history of cardiac disease or cardiac chest pain. All results were negative.
Patient demographics. The average age of our 58 trauma victims was 24 years, with a male:female ratio of 6:1. Fortysix percent of the injuries were stab wounds; automobile and motorcycle accidents accounted for 29%; and gunshot wounds accounted for 13% (Figure 1) .
Degree of injuries. The extent of injury of the 58 trauma victims varied considerably. The most severe injuries involved victims of motorcycleaccidents, who had multiple fractures, abrasions, and perforated viscera. The milder injuries included minor lacerations.
Emergency-room assessment of blunt and penetrating trauma can be fraught with errors; reproducible noninvasive clinical criteria for and total CK as our objective indices of skeletal muscle trauma (6) .
Blunt us penetrating trauma. A portion of our study consisted of subdividing all trauma patients (except six) into two groups, for comparison. Group 1 consisted of 17 subjects who had either an automobile or a motorcycleaccident; Group 2 consisted of 35 subjects who had either a stab or a gunshot wound. The remaining six patients (who had suffered assaults, train accidents, or falls) were too diverse and small a group for comparison purposes. RIA kits. The CK-MM and CK-BB ifiA kits are not available commercially and were given to us by International Immunoassay Labs for research purposes only. Because no other company produces commercially available kits for CK.MM or CK-BB 1UA, we evaluated CK-MM and compared it with our total CK measurement (both measure skeletal muscle damage). Values for CK-BB were compared with clinical evidence or history of head injury sustained during the traumatic event.
Statistics
Pearson's correlation coefficient and ordinary leastsquares regression analysis were used to do two-tail t-tests.
Ninety-five
percent confidence intervals were evaluated on individual predictions given in the Results section (9) .
We used two sample t-tests, with Satterthwaite's approximate t-test when variances were unequal by an F-test (P 0.01), to compare means for the two groups (penetrating vs blunt trauma).
Also, we used analysis of covanance to compare regression estimates for these two groups (9) . 
CK-MB vs Total CK Formulas Unking Total CK with CK-MB
Fitting the ordinary least-squares regression line to the relationship between total CK (x-axis) and CK-MB (y-axis) displayed in Figure 3 , we derived the following formula:
In developing this formula, we used data from all 58 trawna victims. With this formula one can estimate a mean CK-MB value that is attributable to the skeletal muscle trauma alone, by using the patient's total CK value.
Example: If a patient with skeletal muscle trauma is admitted to the hospital with a total CK of 3000 UIL:
CK-MB = 1.75 + 0.00140 (3000) = 5.95
Another way to use our formula is: for every 500-U/L increment in total CK, the CK-MB value should increase by 0.70 EUIL from an initial CK-MB value of 1.75, i.e.:
[(CKJ500) x 0.70] + 1.75 = CK-MB With either calculation, if the patient's CK-MB value is equal to or less than the calculated CK-MB value, then the patient's CK-MB result should not be considered to be increased for that amount of skeletal muscle damage. Interpretation of measured CK-MB values exceeding this calculated mean remains problematic.
The predicted value (95% confidence level) of the reference range of the CK-MB in a patient with a total CK of 3000 UIL is 3.7 to 8.2 EU/L. Unfortunately, the computations necessary to determine such a predicted reference interval are too intricate for rapid, routine clinical application (9).
Blunt vs Penetrating Trauma
We subdivided 52 of the trauma patients (excluding the six patients with train injuries, falls, and assaults) into two groups. Figure 4 shows the differences between the abovedescribed two groups of patients used for comparisons.
The patients in Group 2 never attained a CK-MB value >3 EUIL, whereas the patients in Group 1 had CK-MB values ranging from 2 to 12.6 EUIL (Figure 4) . The wide range of CK-MB values obtained for the two groups is not surprising in view of the individual differences in the amount of skeletal muscle trauma. Evidently, patients involved in motor-vehicle accidents can generally be expect- (6) . Because this portion is ordinarily too small to alter results of CK-MB assays, skeletal muscle has been overlooked as a (potentially) significant source of CK-MB. However, should the absolute amount of total CK arising from skeletal muscle damage be large enough-i.e., severe skeletal muscle trauma-then the proportion of CK-MB in the circulation that has originated from skeletal muscle alone can become substantial.
Because we had observed patients with massive skeletal muscle trauma and increased CK-MB, we investigated the possibility of skeletal muscle as a source of the increased CK-MB, finding increased CK-MB values in 8.6% of 58 consecutive trauma patients, each occurring in the absence of any independent evidence of myocardial damage.
In our study, when the total CK exceeded 884 UIL, a CK-MB value exceeding 5.0 EUIL was found in 38% of the patients (Figure 3 ). In addition, CK-MB increased above 5 EUIL in direct proportion to the increase in total CK, at a relative rate that implied that the CK-MB increase was originating from that small proportion of CK-MB present in (the relatively large amount of) skeletal muscle. Total CK must be taken into account when a trauma patient's CK-MB is evaluated.
The excellent correlation between CK-MM and total CK was to be expected, because both variables reflect skeletal muscle damage. The ultimate advantage of measuring CK-MM rather than total CK is that in both CK-MM and CK-MB the same assay units (EU/L) are used for measurement, while total CK is expressed as UIL. Thus CK-MM and CK-MB values are directly comparable, albeit through a ratio.
Not surprisingly, the great majority of patients with increased CK-BB were those involved in motor-vehicle (particularly motorcycle) accidents, where head injuries are common.
We observed that certain types of trauma (mainly motorvehicle accidents) are associated with increased CK-MB isoenzymes without true myocardial damage, and that the total CK value must be considered together with the CK-MB isoenzyme value.
Physicians faced with ambiguous or unexpected (unexplained) test-result abnormalities face a dilemma, and often feel compelled to order subsequent tests when they would not do so otherwise. With the aid of the formula [CK-MB = 1.75 + 0.00140 (total CK)] we hope to alleviate physicians' concern in assessing the myocardial status of the trauma victims they see.
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